[
  {
    "ts": "2025-11-07T03:17:41+00:00",
    "headline": "Biogen Shares Recover Slightly Amid Clinical Trial Partnerships — Is the Stock Trading Below Fair Value?",
    "summary": "Wondering if Biogen stock is priced for opportunity or risk? You are not alone. There is a lot more beneath the surface to consider when assessing its true value. Recently, Biogen’s share price has seen a modest climb, up 4.8% over the past week and 3.0% in the last month. However, it is still down 9.9% over the past year, pointing to both shifting expectations and evolving market sentiment. Several headlines have caught investor attention, including new clinical trial partnerships and...",
    "url": "https://finance.yahoo.com/news/biogen-shares-recover-slightly-amid-031741637.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "2e1d0b0c-d7f5-38a4-81fa-720106d1a947",
      "content": {
        "id": "2e1d0b0c-d7f5-38a4-81fa-720106d1a947",
        "contentType": "STORY",
        "title": "Biogen Shares Recover Slightly Amid Clinical Trial Partnerships — Is the Stock Trading Below Fair Value?",
        "description": "",
        "summary": "Wondering if Biogen stock is priced for opportunity or risk? You are not alone. There is a lot more beneath the surface to consider when assessing its true value. Recently, Biogen’s share price has seen a modest climb, up 4.8% over the past week and 3.0% in the last month. However, it is still down 9.9% over the past year, pointing to both shifting expectations and evolving market sentiment. Several headlines have caught investor attention, including new clinical trial partnerships and...",
        "pubDate": "2025-11-07T03:17:41Z",
        "displayTime": "2025-11-07T03:17:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I2k3PKJsWIEX9xgEQz8JwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tmSjpFKmBAT61w1lG5.BLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biogen-shares-recover-slightly-amid-031741637.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biogen-shares-recover-slightly-amid-031741637.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]